Showing results (121-130 of 238) with videos related to
Sort By:
Pageof 24
European Heart Journal|March 9, 2006
Cardiovascular diseases in women: a statement from the policy conference of the European Society of CardiologyMarco Stramba-Badiale, Kim M Fox, Silvia G Priori, et al.Circulation Research|July 11, 2006
Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse modelNian Liu, Barbara Colombi, Mirella Memmi, et al.Circulation Research|December 20, 2008
Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardiaMaría Fernández-Velasco, Angélica Rueda, Nicoletta Rizzi, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|February 21, 2025
Genetics in arrhythmogenic cardiomyopathies: where are we now and where are we heading to?Andrea Mazzanti, Deni Kukavica, Alessandro Trancuccio, et al.Circulation Research|January 13, 2004
Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrinSerge Viatchenko-Karpinski, Dmitry Terentyev, Inna Györke, et al.Frontiers in Physiology|January 25, 2021
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada SyndromeVittoria Di Mauro, Paola Ceriotti, Francesco Lodola, et al.Circulation Research|December 20, 2018
Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic VariationWandi Zhu, Andrea Mazzanti, Taylor L Voelker, et al.Biomed Research International|July 24, 2018
Cardiac Magnetic Resonance in Stable Coronary Artery Disease: Added Prognostic Value to Conventional Risk ProfilingOronzo Catalano, Guido Moro, Alessia Mori, et al.JAMA|September 16, 2004
Association of long QT syndrome loci and cardiac events among patients treated with beta-blockersSilvia G Priori, Carlo Napolitano, Peter J Schwartz, et al.Journal of Cardiovascular Electrophysiology|April 20, 2004
Drug-induced torsades de pointes and implications for drug developmentRobert R Fenichel, Marek Malik, Charles Antzelevitch, et al.Pageof 24